3 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Rurioctocog alfa pegol: new trials by email Literature Review of Rurioctocog alfa pegol trials Research Report on Rurioctocog alfa pegol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia A Efanesoctocog alfa, Octocog alfa, Rurioctocog alfa pegol - Hemophilia A | Phase 1 | Completed | Sanofi | 13 | 2021-08-11 | 2025-09-18 |
| Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT® octocog alfa, rurioctocog alfa pegol - Hemophilia A, Hemophilia | Completed | Spanish Society of Thrombosis and Haemostasis | 50 | 2016-11-11 | 2023-06-08 | |
| ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD) ADVATE, ADYNOVI - Hemophilia A | Completed | Baxalta now part of Shire | 951 | 2011-06-28 | 2024-06-17 |
Hemophilia A (3) · Hemarthrosis (1)
Baxalta now part of Shire (1) · Sanofi (1) · Spanish Society of Thrombosis and Haemostasis (1)
Spain (2) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · China (1) · Colombia (1) · Czechia (1) · Denmark (1) · France (1) · Greece (1) · Hungary (1) · Italy (1)